"Graves Ophthalmopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Descriptor ID |
D049970
|
| MeSH Number(s) |
C11.270.842 C11.675.349.500.500 C19.874.283.605.500 C19.874.397.370.500 C20.111.555.500
|
| Concept/Terms |
Graves Ophthalmopathy- Graves Ophthalmopathy
- Ophthalmopathy, Graves
- Ophthalmopathies, Thyroid-Associated
- Ophthalmopathies, Thyroid Associated
- Thyroid-Associated Ophthalmopathies
- Thyroid Associated Ophthalmopathies
- Thyroid-Associated Ophthalmopathy
- Thyroid Associated Ophthalmopathy
- Dysthyroid Ophthalmopathy
- Dysthyroid Ophthalmopathies
- Ophthalmopathies, Dysthyroid
- Ophthalmopathy, Dysthyroid
- Ophthalmopathy, Thyroid-Associated
- Ophthalmopathy, Thyroid Associated
Myopathic Ophthalmopathy- Myopathic Ophthalmopathy
- Myopathic Ophthalmopathies
- Ophthalmopathies, Myopathic
- Ophthalmopathy, Myopathic
Congestive Ophthalmopathy- Congestive Ophthalmopathy
- Congestive Ophthalmopathies
- Ophthalmopathies, Congestive
- Ophthalmopathy, Congestive
- Ophthalmopathy, Infiltrative
- Infiltrative Ophthalmopathies
- Infiltrative Ophthalmopathy
- Ophthalmopathies, Infiltrative
- Edematous Ophthalmopathy
- Edematous Ophthalmopathies
- Ophthalmopathies, Edematous
- Ophthalmopathy, Edematous
|
Below are MeSH descriptors whose meaning is more general than "Graves Ophthalmopathy".
Below are MeSH descriptors whose meaning is more specific than "Graves Ophthalmopathy".
This graph shows the total number of publications written about "Graves Ophthalmopathy" by people in this website by year, and whether "Graves Ophthalmopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Graves Ophthalmopathy" by people in Profiles.
-
Graves' disease and Graves' orbitopathy following COVID-19. J Endocrinol Invest. 2021 Sep; 44(9):2011-2012.
-
Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM). Arch Endocrinol Metab. 2021 Nov 03; 65(3):368-375.
-
Management of Graves Thyroidal and Extrathyroidal Disease: An Update. J Clin Endocrinol Metab. 2020 12 01; 105(12).
-
Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020 Oct; 81(5):507-510.
-
High-Dose Oral Methylprednisolone for the Management of Severe Active Thyroid Eye Disease During the Coronavirus Disease 2019 Pandemic. Ophthalmic Plast Reconstr Surg. 2020 Jul/Aug; 36(4):418-419.
-
Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic. J Endocrinol Invest. 2020 Aug; 43(8):1149-1151.
-
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy. Autoimmun Rev. 2019 Jul; 18(7):673-678.
-
[Nontarget area and threshold selection in 99mTc-DTPA orbital SPECT/CT imaging inthyroid associated ophthalmopathy]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Aug 28; 43(8):869-874.
-
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy. J Endocrinol Invest. 2019 Apr; 42(4):471-480.
-
Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current concepts. Autoimmun Rev. 2018 Jul; 17(7):639-643.